Fig. 6From: MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathwayMUC3A promoted the migration and invasion of CRC through the PI3K/AKT/mTOR signaling pathway. A B Migration and invasion abilities of CRC cells treated with rapamycin (1 µM for 4 h). C Migration ability of CRC cells treated with rapamycin detected by wound healing assay (1 µM for 4 h)Back to article page